References:
1. Breathnach SM, Black MM. Lichen planus and lichenoid disorders. In: Burns T, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. 8th ed., Vol. 2. USA: Blackwell Publishing Company; 2010. p. 41.6-41.11.
2. Weston G, Payette M. Update on lichen planus and its clinical variants. Int J Womens Dermatol.  2015;1(3):140-9.
3. Kastelan M, Prpiæ Massari L, et al. The role of perforin-mediated apoptosis in lichen planus lesions. Arch Dermatol Res 2004; 296 : 226–230.
4. Wakefield PE, James WD, Samlasko CP, Meltzer MS: Tumor necrosis factor. J Am Acad Dermatol 1991;24:675–685.
5. Erdem MT, Gulec AI, Kiziltunc A, et al. Increased serum levels of tumor necrosis factor alpha in lichen planus. Dermatology. 2003;207(4):367-70.
6. Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment. Int J Dermatol. 2002;41(5):282-3.
7. Cassetty CT, Shupack JL, Washenik K. Cytotoxic and antimetabolite agents. In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick’s Dermatology in General Medicine. McGraw- Hill, New York, 2003: 2398–2408.
8. Turan H, Baskan EB, Tunali S, et al. Methotrexate for the treatment of generalized lichen planus. J Am Acad Dermatol 2009; 60: 164-166.
9. Kanwar A, De D. Methotrexate for treatment of lichen planus: old drug, new indication.  J Eur Acad Dermatol Venereol. 2013;27(3):e410-e3.
10. Pavlotsky F, Nathansohn N, Kriger G, et al. Ultraviolet-B treatment for cutaneous lichen planus: our experience with 50 patients. Photodermatol Photoimmunol Photomed. 2008;24(2):83-6.
11. Atzmony L, Reiter O, Hodak E, et al. Treatments for cutaneous lichen planus: a systematic review and meta-analysis. Am J Clin Dermatol. 2016;17(1):11-22.
12. Habib F, Stoebner PE, Picot E, et al. Narrow band UVB phototherapy in the treatment of widespread lichen planus. Ann Dermatol Venereol. 2005; 132(1):17-20.
13. Gamil H, Nassar A, Saadawi A, et al. Narrow-band ultraviolet B phototherapy in lichen planus. J Eur Acad Dermatol Venereol. 2009;23(5):589-90.
14. Chan ESL, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002, 4:266-273.
15. Zhang H, Park Y, Wu J, et al. Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond). 2009; 116(3):219-30.